🇺🇸 FDA
Patent

US 10213395

Toxic aldehyde related diseases and treatment

granted A61KA61K31/13A61K31/137

Quick answer

US patent 10213395 (Toxic aldehyde related diseases and treatment) held by Aldeyra Therapeutics, Inc. expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aldeyra Therapeutics, Inc.
Grant date
Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K31/13, A61K31/137, A61K31/197, A61K31/423